Narcotic-Related Disorders clinical trials
The registry lists 41 studies for Narcotic-Related Disorders across 2 countries. 4 are recruiting or about to start. 3 of them are mainly about Narcotic-Related Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its 4 narrower conditions too, such as Opioid-Related Disorders: 1,649 studies, 302 open.
Get an email when these change. Save the Narcotic-Related Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Member Companies of the Opioid PMR Consortium (10) · ER/LA Opioid REMS Program Companies (RPC) (6) · Georgetown University (4) · Pfizer (2) · Johan Franck (1) · Senthil Sadhasivam (1) · Veterans Recovery Network Inc. (1) · Sharon Walsh (1)
What is being tested here
Drugs under test in Narcotic-Related Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Semaglutide | 1 | 0 | 1 |
| Oxycodone | 0 | 0 | 2 |
| Suvorexant | 0 | 0 | 1 |
| Ondansetron | 0 | 0 | 1 |
| Aprepitant | 0 | 0 | 1 |
| Buprenorphine | 0 | 0 | 1 |
| Naloxone | 0 | 0 | 1 |
| Bupivacaine | 0 | 0 | 1 |
| Pregabalin | 0 | 0 | 1 |
| Acetazolamide | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Apr 2027GLP-1R Agonist Treatment for Opioid Use Disorder · Milton S. Hershey Medical Center
Who these studies take
Of the 2 Narcotic-Related Disorders studies recruiting now, 1 (50%) set no upper age limit and 1 (50%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 2 (100%) | 2 (100%) |
| 85 | 1 (50%) | 1 (50%) |
Across all 41 studies, recruiting or not: 29% stop at 75 or younger and 24% at 65; 24% take children; 5% are for women only and 0% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 41 of 41. search them.
- QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)Not yet recruitingNCT07661823Not applicable1 country
- GLP-1R Agonist Treatment for Opioid Use DisorderRecruitingNCT06548490Phase 21 country
- Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use DisorderEnrolling by invitationNCT064159941 country
- Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management VisitsRecruitingNCT06387290Phase 31 country
- A Systems Analysis and Improvement Approach for Optimizing HIV Service Delivery in Syringe Services ProgramsActive, not recruitingNCT06025435Not applicable1 country
- A Study of Loco-Regional Liposomal Bupivacaine InjectionTerminatedNCT05992896Phase 41 country
- Maternal Brain Imaging in Opioid Use DisorderCompletedNCT060089901 country
- Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)CompletedNCT06023459Phase 31 country
- Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary CareActive, not recruitingNCT06810076Not applicable1 country
- Safe Prescription of Opioids in Primary CareActive, not recruitingNCT05577026Not applicable1 country
- Suvorexant for Opioid/Stimulant Co-useCompletedNCT05546515Phase 21 country
- Treatment Outcomes Among Patients With Prescription Narcotic Drug Use DisorderActive, not recruitingNCT037139831 country
- Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)CompletedNCT06612788Not applicable1 country
- A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic PainCompletedNCT027517621 country
- Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent WomenCompletedNCT01965704Phase 21 country
- Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)CompletedNCT00929253Not applicable1 country
- A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic SurgeriesCompletedNCT034222111 country
- Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid MedicationCompletedNCT02660619
- A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse QuestionnaireCompletedNCT02678507
- Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec ReviewCompletedNCT02667210
- A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse QuestionnaireCompletedNCT026606061 country
- Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or AddictionCompletedNCT02668549
- A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or DiversionCompletedNCT02667158
- Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1BCompletedNCT02667197
- An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims DataCompletedNCT02667262
- Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic PainTerminatedNCT02741076Phase 41 country
- Auricular Acupuncture to Facilitate Outpatient Opioid WeaningTerminatedNCT02882048Not applicable1 country
- The Effects of Opioid Taper on Opioid-Induced HyperalgesiaTerminatedNCT030639051 country
- Aprepitant Effects on Oxycodone ResponseCompletedNCT00999544Not applicable1 country
- The Effects of Water Temperature on the Cold Pressor TestCompletedNCT030836261 country
- Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic PainWithdrawnNCT02276989Phase 21 country
- Increased Sensitivity to Pain Caused by Opioids in People Who Have Abused Prescription OpioidsTerminatedNCT01821430Phase 21 country
- Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator ProductsStatus unknownNCT02925806
- ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and PoisoningStatus unknownNCT02866266
- Evaluation of Changes in Prescribing Behavior of ER/LA Opioid PrescribersStatus unknownNCT02920762
- Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid AnalgesicsStatus unknownNCT02920775
- ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner DatabasesStatus unknownNCT02897414
- Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment CentersStatus unknownNCT02871232
- Buprenorphine and Methadone for Opioid Dependent Chronic Pain PatientsCompletedNCT00879996Phase 41 country
- Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And PlaceboCompletedNCT01595867Phase 1
- A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy VolunteersCompletedNCT01530542Phase 11 country